Cargando…

Prostate brachytherapy in Ghana: our initial experience

PURPOSE: This study presents the experience of a brachytherapy team in Ghana with a focus on technology transfer and outcome. The team was initially proctored by experienced physicians from Europe and South Africa. MATERIAL AND METHODS: A total of 90 consecutive patients underwent either brachythera...

Descripción completa

Detalles Bibliográficos
Autores principales: Mensah, James Edward, Yarney, Joel, Vanderpuye, Verna, Akpakli, Evans, Tagoe, Samuel, Sasu, Evans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116449/
https://www.ncbi.nlm.nih.gov/pubmed/27895678
http://dx.doi.org/10.5114/jcb.2016.62972
_version_ 1782468658648317952
author Mensah, James Edward
Yarney, Joel
Vanderpuye, Verna
Akpakli, Evans
Tagoe, Samuel
Sasu, Evans
author_facet Mensah, James Edward
Yarney, Joel
Vanderpuye, Verna
Akpakli, Evans
Tagoe, Samuel
Sasu, Evans
author_sort Mensah, James Edward
collection PubMed
description PURPOSE: This study presents the experience of a brachytherapy team in Ghana with a focus on technology transfer and outcome. The team was initially proctored by experienced physicians from Europe and South Africa. MATERIAL AND METHODS: A total of 90 consecutive patients underwent either brachytherapy alone or brachytherapy in combination with external beam radiotherapy for prostate carcinoma between July 2008 and February 2014 at Korle Bu Teaching Hospital, Accra, Ghana. Patients were classified as low-risk, intermediate, and high-risk according to the National Comprehensive Cancer Network (NCCN) criteria. All low-risk and some intermediate risk group patients were treated with seed implantation alone. Some intermediate and all high-risk group patients received brachytherapy combined with external beam radiotherapy. RESULTS: The median patient age was 64.0 years (range 46-78 years). The median follow-up was 58 months (range 18-74 months). Twelve patients experienced biochemical failure including one patient who had evidence of metastatic disease and died of prostate cancer. Freedom from biochemical failure rates for low, intermediate, and high-risk cases were 95.4%, 90.9%, and 70.8%, respectively. Clinical parameters predictive of biochemical outcome included: clinical stage, Gleason score, and risk group. Pre-treatment prostate specific antigen (PSA) was not a statistically significant predictor of biochemical failure. Sixty-nine patients (76.6%) experienced grade 1 urinary symptoms in the form of frequency, urgency, and poor stream. These symptoms were mostly self-limiting. Four patients needed catheterization for urinary retention (grade 2). One patient developed a recto urethral fistula (grade 3) following banding for hemorrhoids. CONCLUSIONS: Our results compare favorably with those reported by other institutions with more extensive experience. We believe therefore that, interstitial permanent brachytherapy can be safely and effectively performed in a resource challenged environment if adequate training and proctoring is provided.
format Online
Article
Text
id pubmed-5116449
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-51164492016-11-28 Prostate brachytherapy in Ghana: our initial experience Mensah, James Edward Yarney, Joel Vanderpuye, Verna Akpakli, Evans Tagoe, Samuel Sasu, Evans J Contemp Brachytherapy Original Paper PURPOSE: This study presents the experience of a brachytherapy team in Ghana with a focus on technology transfer and outcome. The team was initially proctored by experienced physicians from Europe and South Africa. MATERIAL AND METHODS: A total of 90 consecutive patients underwent either brachytherapy alone or brachytherapy in combination with external beam radiotherapy for prostate carcinoma between July 2008 and February 2014 at Korle Bu Teaching Hospital, Accra, Ghana. Patients were classified as low-risk, intermediate, and high-risk according to the National Comprehensive Cancer Network (NCCN) criteria. All low-risk and some intermediate risk group patients were treated with seed implantation alone. Some intermediate and all high-risk group patients received brachytherapy combined with external beam radiotherapy. RESULTS: The median patient age was 64.0 years (range 46-78 years). The median follow-up was 58 months (range 18-74 months). Twelve patients experienced biochemical failure including one patient who had evidence of metastatic disease and died of prostate cancer. Freedom from biochemical failure rates for low, intermediate, and high-risk cases were 95.4%, 90.9%, and 70.8%, respectively. Clinical parameters predictive of biochemical outcome included: clinical stage, Gleason score, and risk group. Pre-treatment prostate specific antigen (PSA) was not a statistically significant predictor of biochemical failure. Sixty-nine patients (76.6%) experienced grade 1 urinary symptoms in the form of frequency, urgency, and poor stream. These symptoms were mostly self-limiting. Four patients needed catheterization for urinary retention (grade 2). One patient developed a recto urethral fistula (grade 3) following banding for hemorrhoids. CONCLUSIONS: Our results compare favorably with those reported by other institutions with more extensive experience. We believe therefore that, interstitial permanent brachytherapy can be safely and effectively performed in a resource challenged environment if adequate training and proctoring is provided. Termedia Publishing House 2016-10-11 2016-10 /pmc/articles/PMC5116449/ /pubmed/27895678 http://dx.doi.org/10.5114/jcb.2016.62972 Text en Copyright: © 2016 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Mensah, James Edward
Yarney, Joel
Vanderpuye, Verna
Akpakli, Evans
Tagoe, Samuel
Sasu, Evans
Prostate brachytherapy in Ghana: our initial experience
title Prostate brachytherapy in Ghana: our initial experience
title_full Prostate brachytherapy in Ghana: our initial experience
title_fullStr Prostate brachytherapy in Ghana: our initial experience
title_full_unstemmed Prostate brachytherapy in Ghana: our initial experience
title_short Prostate brachytherapy in Ghana: our initial experience
title_sort prostate brachytherapy in ghana: our initial experience
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116449/
https://www.ncbi.nlm.nih.gov/pubmed/27895678
http://dx.doi.org/10.5114/jcb.2016.62972
work_keys_str_mv AT mensahjamesedward prostatebrachytherapyinghanaourinitialexperience
AT yarneyjoel prostatebrachytherapyinghanaourinitialexperience
AT vanderpuyeverna prostatebrachytherapyinghanaourinitialexperience
AT akpaklievans prostatebrachytherapyinghanaourinitialexperience
AT tagoesamuel prostatebrachytherapyinghanaourinitialexperience
AT sasuevans prostatebrachytherapyinghanaourinitialexperience